B cell depletion and SARS‐CoV‐2 vaccine responses in neuroimmunologic patients
B Kornek, F Leutmezer, PS Rommer… - Annals of …, 2022 - Wiley Online Library
Objective The study was undertaken to assess the impact of B cell depletion on humoral and
cellular immune responses to severe acute respiratory syndrome‐coronavirus 2 (SARS …
cellular immune responses to severe acute respiratory syndrome‐coronavirus 2 (SARS …
Long-term analysis of antibodies elicited by SPUTNIK V: A prospective cohort study in Tucumán, Argentina
RE Chahla, RH Tomas-Grau, SI Cazorla… - The Lancet Regional …, 2022 - thelancet.com
Summary Background Gam-COVID-Vac (SPUTNIK V) has been granted emergency use
authorization in 70 nations and has been administered to millions worldwide. However …
authorization in 70 nations and has been administered to millions worldwide. However …
Neutralizing antibody titers six months after Comirnaty vaccination: kinetics and comparison with SARS-CoV-2 immunoassays
Objectives mRNA vaccines, including Comirnaty (BNT162b2 mRNA, BioNTech-Pfizer), elicit
high IgG and neutralizing antibody (NAb) responses after the second dose, but the …
high IgG and neutralizing antibody (NAb) responses after the second dose, but the …
Dynamics of anti-Spike IgG antibody level after the second BNT162b2 COVID-19 vaccination in health care workers
H Ikezaki, H Nomura, N Shimono - Journal of Infection and Chemotherapy, 2022 - Elsevier
Introduction Many countries are administering a third dose of COVID-19 vaccines, but the
evaluation of vaccine-induced immunity is insufficient. In addition, there are few reports of …
evaluation of vaccine-induced immunity is insufficient. In addition, there are few reports of …
Clinical and immunological features of SARS-CoV-2 breakthrough infections in vaccinated individuals requiring hospitalization
Abstract Background and Purpose Waning immunity and the surge of SARS-CoV-2 variants
are responsible for breakthrough infections, ie, infections in fully vaccinated individuals …
are responsible for breakthrough infections, ie, infections in fully vaccinated individuals …
Immunogenicity and real-world effectiveness of COVID-19 vaccines in Lebanon: Insights from primary and booster schemes, variants, infections, and hospitalization
R Moghnieh, W Haddad, N Jbeily, S El-Hassan, S Eid… - Plos one, 2024 - journals.plos.org
In this study, we conducted a case-control investigation to assess the immunogenicity and
effectiveness of primary and first booster homologous and heterologous COVID-19 …
effectiveness of primary and first booster homologous and heterologous COVID-19 …
Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after …
D Firinu, A Perra, M Campagna, R Littera… - Clinical and …, 2022 - Springer
SARS-CoV-2 vaccination with mRNA product BNT162b2 elicited high immunogenicity in
healthy subjects in trials. This study aims to better understand the factors that influence the …
healthy subjects in trials. This study aims to better understand the factors that influence the …
Humoral immune response after COVID-19 infection or BNT162b2 vaccine among older adults: evolution over time and protective thresholds
M Meyer, F Constancias, C Worth, A Meyer, M Muller… - Geroscience, 2022 - Springer
The objectives of this study were to assess the dynamics of the SARS-CoV-2 anti-RBD-IgG
response over time among older people after COVID-19 infection or vaccination and its …
response over time among older people after COVID-19 infection or vaccination and its …
[HTML][HTML] Dynamics of SARS-CoV-2 antibody response to CoronaVac followed by booster dose of BNT162b2 vaccine
We evaluated the longitudinal dynamics of antibody response to the SARS-CoV-2 vaccine
CoronaVac and the effect of a booster dose of BNT162b2 vaccine. We found a robust …
CoronaVac and the effect of a booster dose of BNT162b2 vaccine. We found a robust …
[HTML][HTML] Systems biology analysis reveals distinct molecular signatures associated with immune responsiveness to the BNT162b COVID-19 vaccine
I Odak, L Riemann, I Sandrock, A Cossmann… - …, 2024 - thelancet.com
Background Human immune responses to COVID-19 vaccines display a large heterogeneity
of induced immunity and the underlying immune mechanisms for this remain largely …
of induced immunity and the underlying immune mechanisms for this remain largely …